Treatment of Streptozotocin-Induced Diabetic Rats with Alogliptin: Effect on Vascular and Neural Complications

Table 1

Effect of treatment of streptozotocin-diabetic rats with alogliptin on change in body weight, blood glucose and hemoglobin A₁C.

Determination	Control; (11)	Diabetic; (12)	Diabetic + Alogliptin; (9)
Start weight (g)	359 ± 4	362 ± 4	358 ± 6
End weight (g)	524 ± 9	334 ± 14^a	373 ± 30^a
Blood glucose (mg/dL)	110 ± 5	578 ± 13^a	536 ± 23^a
Hb A1C (%)	5.3 ± 0.3	13.9 ± 0.4^a	13.1 ± 1.4^a

Data are presented as the mean ± SEM. ^aP < 0.05 compared to control. Parentheses indicate the number of experimental animals.